Given that hepatocytes commonly express insulin receptors, we hypothesize that endogenous hyperinsulinemia may partly drive hepatic secretion of LEAP2 in patients with insulinoma (Figure 4). The gene discussed is INSR; the disease is hyperinsulinism.